{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:55:19Z","timestamp":1793505319961,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG054057"],"award-info":[{"award-number":["R01AG054057"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG017917"],"award-info":[{"award-number":["R01AG017917"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":[".."],"award-info":[{"award-number":[".."]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41380-022-01802-5","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T11:04:26Z","timestamp":1664881466000},"page":"4307-4313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Brain copper may protect from cognitive decline and Alzheimer\u2019s disease pathology: a community-based study"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-6653","authenticated-orcid":false,"given":"Puja","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-2427","authenticated-orcid":false,"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2375-8888","authenticated-orcid":false,"given":"Sonal","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klodian","family":"Dhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-1665","authenticated-orcid":false,"given":"Sue E.","family":"Leurgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9069","authenticated-orcid":false,"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-1752","authenticated-orcid":false,"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"1802_CR1","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","volume":"273","author":"CS Atwood","year":"1998","unstructured":"Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, et al. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem. 1998;273:12817\u201326.","journal-title":"J Biol Chem"},{"key":"1802_CR2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","volume":"75","author":"CS Atwood","year":"2000","unstructured":"Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, et al. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem. 2000;75:1219\u201333.","journal-title":"J Neurochem"},{"key":"1802_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsb.2005.09.004","volume":"155","author":"LM Miller","year":"2006","unstructured":"Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer\u2019s disease. J Struct Biol. 2006;155:30\u20137.","journal-title":"J Struct Biol"},{"key":"1802_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JAD-201556","volume":"83","author":"R Squitti","year":"2021","unstructured":"Squitti R, Faller P, Hureau C, Granzotto A, White AR, Kepp KP. Copper Imbalance in Alzheimer\u2019s Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology. J Alzheimer\u2019s Dis: JAD. 2021;83:23\u201341.","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1802_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fnagi.2017.00300","volume":"9","author":"DD Li","year":"2017","unstructured":"Li DD, Zhang W, Wang ZY, Zhao P. Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer\u2019s Disease: A Meta-Analysis of Case-Control Studies. Front Aging Neurosci. 2017;9:300.","journal-title":"Front Aging Neurosci"},{"key":"1802_CR6","doi-asserted-by":"crossref","first-page":"14193","DOI":"10.1073\/pnas.2332851100","volume":"100","author":"AL Phinney","year":"2003","unstructured":"Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, et al. In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci. 2003;100:14193\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"1802_CR7","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. Embo j. 2017;36:2473\u201387.","journal-title":"Embo j"},{"key":"1802_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2008.09.039","volume":"46","author":"S Itoh","year":"2009","unstructured":"Itoh S, Ozumi K, Kim HW, Nakagawa O, McKinney RD, Folz RJ, et al. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. Free Radic Biol Med. 2009;46:95\u2013104.","journal-title":"Free Radic Biol Med"},{"key":"1802_CR9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.tips.2018.10.001","volume":"39","author":"SL Sensi","year":"2018","unstructured":"Sensi SL, Granzotto A, Siotto M, Squitti R. Copper and Zinc Dysregulation in Alzheimer\u2019s Disease. Trends Pharm Sci. 2018;39:1049\u201363.","journal-title":"Trends Pharm Sci"},{"key":"1802_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/nbdi.1999.0250","volume":"6","author":"DJ Waggoner","year":"1999","unstructured":"Waggoner DJ, Bartnikas TB, Gitlin JD. The role of copper in neurodegenerative disease. Neurobiol Dis. 1999;6:221\u201330.","journal-title":"Neurobiol Dis"},{"key":"1802_CR11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archneur.63.8.1085","volume":"63","author":"MC Morris","year":"2006","unstructured":"Morris MC, Evans DA, Tangney CC, Bienias JL, Schneider JA, Wilson RS, et al. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol. 2006;63:1085\u20138.","journal-title":"Arch Neurol"},{"key":"1802_CR12","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.jand.2021.06.002","volume":"121","author":"X Wang","year":"2021","unstructured":"Wang X, Li X, Xing Y, Wang W, Li S, Zhang D, et al. Threshold Effects of Total Copper Intake on Cognitive Function in US Older Adults and the Moderating Effect of Fat and Saturated Fatty Acid Intake. J Acad Nutr Diet. 2021;121:2429\u201342.","journal-title":"J Acad Nutr Diet"},{"key":"1802_CR13","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious Orders Study and Rush Memory and Aging Project. J Alzheimer\u2019s Dis: JAD. 2018;64:S161\u2013S189.","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1802_CR14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwg290","volume":"158","author":"MC Morris","year":"2003","unstructured":"Morris MC. Validity and Reproducibility of a Food Frequency Questionnaire by Cognition in an Older Biracial Sample. Am J Epidemiol. 2003;158:1213\u20137.","journal-title":"Am J Epidemiol"},{"key":"1802_CR15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1212\/WNL.0000000000001935","volume":"85","author":"RS Wilson","year":"2015","unstructured":"Wilson RS, Boyle PA, Yu L, Barnes LL, Sytsma J, Buchman AS, et al. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology 2015;85:984\u201391.","journal-title":"Neurology"},{"key":"1802_CR16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837\u201344.","journal-title":"Neurology"},{"key":"1802_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","volume":"85","author":"PA Boyle","year":"2019","unstructured":"Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, et al. Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies. Ann Neurol. 2019;85:114\u201324.","journal-title":"Ann Neurol"},{"key":"1802_CR18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"DA Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004;61:378\u201384.","journal-title":"Arch Neurol"},{"key":"1802_CR19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 1991;41:479\u201386.","journal-title":"Neurology"},{"key":"1802_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica. 1991;82:239\u201359.","journal-title":"Acta Neuropathologica"},{"key":"1802_CR21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0197-4580(97)00057-2","volume":"18","author":"Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease.","year":"1997","unstructured":"Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u2019s Disease. Neurobiol Aging. 1997;18:S1\u20132.","journal-title":"Neurobiol Aging"},{"key":"1802_CR22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1212\/WNL.0000000000003614","volume":"88","author":"L Yu","year":"2017","unstructured":"Yu L, Lutz MW, Wilson RS, Burns DK, Roses AD, Saunders AM, et al. TOMM40'523 variant and cognitive decline in older persons with APOE epsilon3\/3 genotype. Neurology 2017;88:661\u20138.","journal-title":"Neurology"},{"key":"1802_CR23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000096129","volume":"27","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, et al. Decision rules guiding the clinical diagnosis of Alzheimer\u2019s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006;27:169\u201376.","journal-title":"Neuroepidemiology"},{"key":"1802_CR24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/S1355617705050459","volume":"11","author":"RS Wilson","year":"2005","unstructured":"Wilson RS, Barnes LL, Krueger KR, Hoganson G, Bienias JL, Bennett DA. Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc. 2005;11:400\u20137.","journal-title":"J Int Neuropsychol Soc"},{"key":"1802_CR25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/mus.20702","volume":"35","author":"AS Buchman","year":"2007","unstructured":"Buchman AS, Boyle PA, Wilson RS, Bienias JL, Bennett DA. Physical activity and motor decline in older persons. Muscle Nerve. 2007;35:354\u201362.","journal-title":"Muscle Nerve"},{"key":"1802_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/1028415X.2020.1769411","volume":"25","author":"P Agarwal","year":"2020","unstructured":"Agarwal P, Wang Y, Buchman AS, Holland TM, Bennett DA, Morris MC. Dietary antioxidants associated with slower progression of parkinsonian signs in older adults. Nutritional Neurosci. 2020;25:550\u2013557. https:\/\/doi.org\/10.1080\/1028415X.2020.1769411.","journal-title":"Nutritional Neurosci"},{"key":"1802_CR27","doi-asserted-by":"crossref","unstructured":"Willett WC Implication of Total Energy Intake fo Epidemiological Analyses, vol. Third Edition 2013, 260-286pp.","DOI":"10.1093\/acprof:oso\/9780199754038.003.0011"},{"key":"1802_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2007.02.077","volume":"418","author":"S Magaki","year":"2007","unstructured":"Magaki S, Raghavan R, Mueller C, Oberg KC, Vinters HV, Kirsch WMIron. copper, and iron regulatory protein 2 in Alzheimer\u2019s disease and related dementias. Neurosci Lett. 2007;418:72\u20136.","journal-title":"Neurosci Lett"},{"key":"1802_CR29","first-page":"623241","volume":"2013","author":"A Rembach","year":"2013","unstructured":"Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, et al. Decreased copper in Alzheimer\u2019s disease brain is predominantly in the soluble extractable fraction. Int J Alzheimers Dis. 2013;2013:623241\u2013623241.","journal-title":"Int J Alzheimers Dis"},{"key":"1802_CR30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pneurobio.2011.05.001","volume":"94","author":"M Schrag","year":"2011","unstructured":"Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM. Iron, zinc and copper in the Alzheimer\u2019s disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol. 2011;94:296\u2013306.","journal-title":"Prog Neurobiol"},{"key":"1802_CR31","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1074\/jbc.M116.754101","volume":"292","author":"H Gerber","year":"2017","unstructured":"Gerber H, Wu F, Dimitrov M, Garcia Osuna GM, Fraering PC. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by \u03b3-Secretase and Amyloid-\u03b2 Peptide Production. J Biol Chem. 2017;292:3751\u201367.","journal-title":"J Biol Chem"},{"key":"1802_CR32","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1074\/jbc.M110.128512","volume":"286","author":"KM Acevedo","year":"2011","unstructured":"Acevedo KM, Hung YH, Dalziel AH, Li Q-X, Laughton K, Wikhe K, et al. Copper promotes the trafficking of the amyloid precursor protein. J Biol Chem. 2011;286:8252\u201362.","journal-title":"J Biol Chem"},{"key":"1802_CR33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BJ20080103","volume":"412","author":"MA Cater","year":"2008","unstructured":"Cater MA, McInnes KT, Li QX, Volitakis I, La Fontaine S, Mercer JF, et al. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms. Biochem J. 2008;412:141\u201352.","journal-title":"Biochem J"},{"key":"1802_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","volume":"59","author":"PA Adlard","year":"2008","unstructured":"Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, et al. Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 2008;59:43\u201355.","journal-title":"Neuron"},{"key":"1802_CR35","doi-asserted-by":"crossref","first-page":"e17669","DOI":"10.1371\/journal.pone.0017669","volume":"6","author":"PA Adlard","year":"2011","unstructured":"Adlard PA, Bica L, White AR, Nurjono M, Filiz G, Crouch PJ, et al. Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer\u2019s disease. PloS One. 2011;6:e17669.","journal-title":"PloS One"},{"key":"1802_CR36","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1073\/pnas.2332818100","volume":"100","author":"TA Bayer","year":"2003","unstructured":"Bayer TA, Sch\u00e4fer S, Simons A, Kemmling A, Kamer T, Tepest R, et al. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci. 2003;100:14187\u201392.","journal-title":"Proc Natl Acad Sci"},{"key":"1802_CR37","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","volume":"7","author":"L Lannfelt","year":"2008","unstructured":"Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, et al. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008;7:779\u201386.","journal-title":"Lancet Neurol"},{"key":"1802_CR38","doi-asserted-by":"crossref","first-page":"104810","DOI":"10.1016\/j.nbd.2020.104810","volume":"139","author":"I Diouf","year":"2020","unstructured":"Diouf I, Bush AI, Ayton S. Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying \u03b2-amyloid pathology. Neurobiol Dis. 2020;139:104810.","journal-title":"Neurobiol Dis"},{"key":"1802_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12011-014-0094-5","volume":"161","author":"S Giacoppo","year":"2014","unstructured":"Giacoppo S, Galuppo M, Calabr\u00f2 RS, D\u2019Aleo G, Marra A, Sessa E, et al. Heavy metals and neurodegenerative diseases: an observational study. Biol Trace Elem Res. 2014;161:151\u201360.","journal-title":"Biol Trace Elem Res"},{"key":"1802_CR40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00702-008-0136-2","volume":"115","author":"H Kessler","year":"2008","unstructured":"Kessler H, Pajonk FG, Bach D, Schneider-Axmann T, Falkai P, Herrmann W, et al. Effect of copper intake on CSF parameters in patients with mild Alzheimer\u2019s disease: a pilot phase 2 clinical trial. J Neural Transm (Vienna). 2008;115:1651\u20139.","journal-title":"J Neural Transm (Vienna)"},{"key":"1802_CR41","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/01.WNL.0000134666.64593.BA","volume":"63","author":"K Yaffe","year":"2004","unstructured":"Yaffe K, Clemons TE, McBee WL, Lindblad AS. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology 2004;63:1705\u20137.","journal-title":"Neurology"},{"key":"1802_CR42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s43188-020-00043-4","volume":"36","author":"M Lamtai","year":"2020","unstructured":"Lamtai M, Zghari O, Ouakki S, Marmouzi I, Mesfioui A, El Hessni A, et al. Chronic copper exposure leads to hippocampus oxidative stress and impaired learning and memory in male and female rats. Toxicol Res. 2020;36:359\u201366.","journal-title":"Toxicol Res"},{"key":"1802_CR43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/toxsci\/kfy082","volume":"164","author":"H Yu","year":"2018","unstructured":"Yu H, Jiang X, Lin X, Zhang Z, Wu D, Zhou L, et al. Hippocampal Subcellular Organelle Proteomic Alteration of Copper-Treated Mice. Toxicological Sci: Off J Soc Toxicol. 2018;164:250\u201363.","journal-title":"Toxicological Sci: Off J Soc Toxicol"},{"key":"1802_CR44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JAD-141776","volume":"44","author":"J Yu","year":"2015","unstructured":"Yu J, Luo X, Xu H, Ma Q, Yuan J, Li X, et al. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer\u2019s disease using proteomic analysis. J Alzheimer\u2019s Dis: JAD. 2015;44:455\u201369.","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"key":"1802_CR45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.toxlet.2016.10.009","volume":"263","author":"X Lin","year":"2016","unstructured":"Lin X, Wei G, Huang Z, Qu Z, Huang X, Xu H, et al. Mitochondrial proteomic alterations caused by long-term low-dose copper exposure in mouse cortex. Toxicol Lett. 2016;263:16\u201325.","journal-title":"Toxicol Lett"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01802-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01802-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01802-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:53:25Z","timestamp":1680864805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01802-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1038\/s41380-022-01802-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AIB Holds equity: Alterity Biotechnology Ltd, Cogstate Ltd, Mesoblast Ltd, Collaborative Medicinal Development LLC. Paid consultant: Collaborative Medicinal Development Pty Ltd. Julie A Schneider\u00a0and other\u00a0 authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}